72 results
FWP
DMKPQ
DMK Pharmaceuticals Corporation
27 Jul 23
Free writing prospectus
6:08am
on third parties to conduct nonclinical and clinical studies, supply raw materials, and manufacture the Company’s products and product candidates
DEFM14A
DMKPQ
DMK Pharmaceuticals Corporation
13 Apr 23
Proxy related to merger
4:52pm
, we rely on third parties to supply the raw materials needed to manufacture our existing and potential products. Any business interruptions resulting
424B5
1bst 646d3jvcyykub
29 Jan 21
Prospectus supplement for primary offering
5:15pm
8-K
EX-99.1
gvgx41mlqkz nv0pixb
28 Jan 21
Updated Summary Business Information
4:26pm
424B5
7z460vx
28 Jan 21
Prospectus supplement for primary offering
4:08pm
8-K
EX-99.1
fekcf8e
5 Oct 20
Report of Independent Registered Public Accounting Firm
5:25pm
8-K
EX-99.2
o68byg1r00xghbukz6
5 Oct 20
Report of Independent Registered Public Accounting Firm
5:25pm
424B5
igythulgmjg7met7
21 Sep 20
Prospectus supplement for primary offering
6:03am